Supplements And Featured Publications
Advancing Myelofibrosis Care: Balancing Clinical Innovation With Economic Impact
The future of diabetes management: expanding access to and impact of CGM for patients with type 2 diabetes
Sponsored by Dexcom, Inc.
The Evolving Landscape of Pediatric Atopic Dermatitis Management
Pulmonary arterial hypertension: Advances and implications for managed care
Conference Brief: Asembia’s AXS25 Summit: A Special Report on Specialty Pharmacy
Advancing Hyperlipidemia Management: Nonstatin Therapies in Guideline-Based Care
Sponsored by Esperion.
The lingering threat of COVID-19 Confronting its burden in 2025
Supporting Families Optimizing Employee Fertility Benefits
Atopic Dermatitis in the Modern Era Assessing Patient Outcomes and Economic Burden
Advances in the Treatment of IgA Nephropathy
Update on RNA-Based Technology
Sponsored by Alnylam Pharmaceuticals, Inc.
Progress in Addressing Hyperlipidemia in the Primary Prevention Setting
Synergie Medication Collective Innovating for Medication Cost Savings
Demodex blepharitis: Navigating Diagnosis and Management Challenges
Understanding the Average Sales Price Landscape
Volume: 33
Issue: 10
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Sponsored: The Teva Biosimilars Trend Report
2
Topical Ruxolitinib Cream Rapidly Repigments Vitiligo Lesions, Study Finds
3
AI Crucial Tool for Patient Management, Lowering Readmission Risk, Expert Says
4
FDA Accepts NDA for Investigational Maintenance Asthma Treatment
5
